Fujifilm to restart clinical trial of Avigan to treat COVID-19 -media ...Middle East

Daily Sun - News
Fujifilm to restart clinical trial of Avigan to treat COVID-19 -media
TOKYO, Feb 21: Fujifilm Holdings Corp will restart a clinical trial in Japan of its antiviral drug Avigan for the treatment of COVID-19, the Nikkei newspaper reported on Sunday.Domestic approval of the drug was delayed after a health ministry panel said in December that trial data was inconclusive. The new study will involve about 270 patients and Fujifilm will aim to seek approval again in October, Nikkei said.Representatives from Fujifilm did not immediately respond to a request for comment.Japan has approved Avigan, known generically as favipiravir, as an emergency flu medicine. But concerns remain, as the drug has been shown to cause birth defects in animal studies and its effectiveness

Hence then, the article about fujifilm to restart clinical trial of avigan to treat covid 19 media was published today ( ) and is available on Daily Sun ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Fujifilm to restart clinical trial of Avigan to treat COVID-19 -media )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News